Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Accelerating the Development of Measles and Rubella Microarray Patches to Eliminate Measles and Rubella: Recent Progress, Remaining Challenges
Authors
Keywords
-
Journal
Frontiers in Public Health
Volume 10, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2022-03-02
DOI
10.3389/fpubh.2022.809675
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A dangerous measles future looms beyond the COVID-19 pandemic
- (2021) David N. Durrheim et al. NATURE MEDICINE
- Formulation Development and Improved Stability of a Combination Measles and Rubella Live-Viral Vaccine Dried for Use in the NanopatchTM Microneedle Delivery System
- (2021) Ying Wan et al. Human Vaccines & Immunotherapeutics
- A global collaboration to advance vaccine product innovations – The Vaccine Innovation Prioritisation Strategy
- (2021) Debra Kristensen et al. VACCINE
- Feasibility assessment of measles and rubella eradication
- (2021) William J. Moss et al. VACCINE
- Return On Investment From Immunization Against 10 Pathogens In 94 Low- And Middle-Income Countries, 2011–30
- (2020) So Yoon Sim et al. HEALTH AFFAIRS
- Routine childhood immunisation during the COVID-19 pandemic in Africa: a benefit–risk analysis of health benefits versus excess risk of SARS-CoV-2 infection
- (2020) Kaja Abbas et al. Lancet Global Health
- Potential use of microarray patches for vaccine delivery in low- and middle- income countries
- (2019) Nicolas Peyraud et al. VACCINE
- A Microneedle Patch for Measles and Rubella Vaccination Is Immunogenic and Protective in Infant Rhesus Macaques
- (2018) Jessica C Joyce et al. JOURNAL OF INFECTIOUS DISEASES
- Safety, tolerability, acceptability and immunogenicity of an influenza vaccine delivered to human skin by a novel high-density microprojection array patch (Nanopatch™)
- (2018) Germain J.P. Fernando et al. VACCINE
- The safety, immunogenicity, and acceptability of inactivated influenza vaccine delivered by microneedle patch (TIV-MNP 2015): a randomised, partly blinded, placebo-controlled, phase 1 trial
- (2017) Nadine G Rouphael et al. LANCET
- Potential Cost-Effectiveness of an Influenza Vaccination Program Offering Microneedle Patch for Vaccine Delivery in Children
- (2017) Carlos Wong et al. PLoS One
- Assessing the Potential Cost-Effectiveness of Microneedle Patches in Childhood Measles Vaccination Programs: The Case for Further Research and Development
- (2016) Bishwa B. Adhikari et al. Drugs in research & development
- Influenza Vaccine Manufacturing: Effect of Inactivation, Splitting and Site of Manufacturing. Comparison of Influenza Vaccine Production Processes
- (2016) Theone C. Kon et al. PLoS One
- An economic model assessing the value of microneedle patch delivery of the seasonal influenza vaccine
- (2015) Bruce Y. Lee et al. VACCINE
- Vaccine instability in the cold chain: Mechanisms, analysis and formulation strategies
- (2014) Ozan S. Kumru et al. BIOLOGICALS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started